Mohammad K. Hararah

Mohammad K. Hararah

Auto-generated profile, based on publicly available information

Mohammad K. Hararah

Department of Otolaryngology University of Colorado School of Medicine Aurora U.S.A.

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
AOAyman Oweida
Ayman Oweida
MHMohammad K. Hararah
Mohammad K. Hararah
APAndy Phan
Andy Phan
DBDavid Binder
David Binder
SBShilpa Bhatia
Shilpa Bhatia
SKSana D. Karam
Sana D. Karam
Purpose: Radiotherapy (RT) can transform the immune landscape and render poorly immunogenic tumors sensitive to PD-L1 inhibition. Here, we established that the response to combined RT and PD-L1 inhibition is transient and investigated mechanisms of resistance. Experimental Design: Mechanisms of resistance to RT and PD-L1 blockade were investigated in orthotopic murine head and neck squamous cell carcinoma (HNSCC) tumors using mass cytometry and whole-genome sequencing. Mice were treated with anti–PD-L1 or anti–TIM-3 alone and in combination with and without RT. Tumor growth and survival were assessed. Flow cytometry was used to assess phenotypic and functional changes in intratumoral T-cell populations. Depletion of regulatory T cells (Treg) was performed using anti-CD25 antibody. Results: We show that the immune checkpoint receptor, TIM-3, is upregulated on CD8 T cells and Tregs in tumors treated with RT and PD-L1 blockade. Treatment with anti–TIM-3 concurrently with anti–PD-L1 and RT led to significant tumor growth delay, enhanced T-cell cytotoxicity, decreased Tregs, and improved survival in orthotopic models of HNSCC. Despite this treatment combination, the response was not durable, and analysis of relapsed tumors revealed resurgence of Tregs. Targeted Treg depletion, however, restored antitumor immunity in mice treated with RT and dual immune checkpoint blockade and resulted in tumor rejection and induction of immunologic memory. Conclusions: These data reveal multiple layers of immune regulation that can promote tumorigenesis and the therapeutic potential of sequential targeting to overcome tumor resistance mechanisms. We propose that targeted Treg inhibitors may be critical for achieving durable tumor response with combined radiotherapy and immunotherapy. Clin Cancer Res; 24(21); 5368–80. ©2018 AACR.

1 March 2019 in Oral Oncology
Verified
Journal Article
Closed access
AGAbhinav Gupta
Abhinav Gupta
WSWilliam Stokes
William Stokes
MEMegan Eguchi
Megan Eguchi
MHMohammad Hararah
Mohammad Hararah
AAArya Amini
Arya Amini
SKSana D. Karam
Sana D. Karam

12 April 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MHMohammad K. Hararah
Mohammad K. Hararah
WSWilliam A. Stokes
William A. Stokes
AOAyman Oweida
Ayman Oweida
TPTejas Patil
Tejas Patil
AAArya Amini
Arya Amini
SKSana D. Karam
Sana D. Karam

1 September 2018 in Otolaryngology Case Reports
Verified
Journal Article
Open access
JCJason E. Cohn
Jason E. Cohn
MSMofiyinfolu Sokoya
Mofiyinfolu Sokoya
MHMohammad Hararah
Mohammad Hararah
SKSameep Kadakia
Sameep Kadakia
YDYadranko Ducic
Yadranko Ducic